skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 368  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Database: ROAD: Directory of Open Access Scholarly Resources remove Database: Taylor & Francis Open Access remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Familial Hypertrophic Cardiomyopathy: Diagnosis and Management
Familial Hypertrophic Cardiomyopathy: Diagnosis and Management
Material Type:
Article 		Add to My Research

Familial Hypertrophic Cardiomyopathy: Diagnosis and Management

Vascular health and risk management, 2023-01, Vol.19, p.211-221 [Peer Reviewed Journal]

2023 Litt et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Litt et al. 2023 Litt et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S365001 ;PMID: 37050929

Full text available

Citations Cited by
2
Stress-induced cardiomyopathy (Takotsubo)--broken heart and mind?
Stress-induced cardiomyopathy (Takotsubo)--broken heart and mind?
Material Type:
Article 		Add to My Research

Stress-induced cardiomyopathy (Takotsubo)--broken heart and mind?

Vascular health and risk management, 2013-01, Vol.9 (default), p.149-154 [Peer Reviewed Journal]

COPYRIGHT 2013 Dove Medical Press Limited ;COPYRIGHT 2013 Dove Medical Press Limited ;2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Redfors et al, publisher and licensee Dove Medical Press Ltd 2013 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/vhrm.s40163 ;PMID: 23626469

Full text available

Citations Cited by
3
Clinical Trials in Hypertrophic Cardiomyopathy Therapy: A Comprehensive Analysis of Trials Registered in Global Clinical Databases
Clinical Trials in Hypertrophic Cardiomyopathy Therapy: A Comprehensive Analysis of Trials Registered in Global Clinical Databases
Material Type:
Article 		Add to My Research

Clinical Trials in Hypertrophic Cardiomyopathy Therapy: A Comprehensive Analysis of Trials Registered in Global Clinical Databases

Drug design, development and therapy, 2023-01, Vol.17, p.1863-1877 [Peer Reviewed Journal]

2023 Zhang et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Zhang et al. 2023 Zhang et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S413136 ;PMID: 37377648

Full text available

Citations Cited by
4
Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies
Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies
Material Type:
Article 		Add to My Research

Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies

Vascular health and risk management, 2010-01, Vol.6 (default), p.883-903 [Peer Reviewed Journal]

2010. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2010 Voulgari et al, publisher and licensee Dove Medical Press Ltd. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/vhrm.s11681 ;PMID: 21057575

Full text available

Citations Cited by
5
Efficacy and safety of mavacamten in treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis
Efficacy and safety of mavacamten in treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Efficacy and safety of mavacamten in treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis

Future science OA, 2023-12, Vol.9 (10), p.FSO898-FSO898 [Peer Reviewed Journal]

2023 The Authors ;2023 The Authors 2023 ;ISSN: 2056-5623 ;EISSN: 2056-5623 ;DOI: 10.2144/fsoa-2023-0059

Full text available

Citations Cited by
6
Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats
Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats
Material Type:
Article 		Add to My Research

Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats

Drug design, development and therapy, 2016-01, Vol.10, p.2095-2107 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Al-Rasheed et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/dddt.s109287 ;PMID: 27418808

Full text available

Citations Cited by
7
U-shaped association between serum uric acid concentration and mortality in hypertrophic cardiomyopathy patients
U-shaped association between serum uric acid concentration and mortality in hypertrophic cardiomyopathy patients
Material Type:
Article 		Add to My Research

U-shaped association between serum uric acid concentration and mortality in hypertrophic cardiomyopathy patients

Upsala journal of medical sciences, 2020-02, Vol.125 (1), p.44-51 [Peer Reviewed Journal]

2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 The Author(s) ;ISSN: 0300-9734 ;EISSN: 2000-1967 ;DOI: 10.1080/03009734.2020.1719245 ;PMID: 32013714

Full text available

Citations Cited by
8
Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics
Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics
Material Type:
Article 		Add to My Research

Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics

Pharmacogenomics and personalized medicine, 2021-01, Vol.14, p.1169-1184 [Peer Reviewed Journal]

2021 Huang et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Huang et al. 2021 Huang et al. ;ISSN: 1178-7066 ;EISSN: 1178-7066 ;DOI: 10.2147/PGPM.S323379 ;PMID: 34557019

Full text available

Citations Cited by
9
Extracorporeal Membrane Oxygenation in Septic Cardiomyopathy Caused by Aspergillus Infection: The First Case Report
Extracorporeal Membrane Oxygenation in Septic Cardiomyopathy Caused by Aspergillus Infection: The First Case Report
Material Type:
Article 		Add to My Research

Extracorporeal Membrane Oxygenation in Septic Cardiomyopathy Caused by Aspergillus Infection: The First Case Report

Infection and drug resistance, 2024-01, Vol.17, p.1303-1307 [Peer Reviewed Journal]

2024 Wu et al. ;COPYRIGHT 2024 Dove Medical Press Limited ;2024 Wu et al. 2024 Wu et al. ;ISSN: 1178-6973 ;EISSN: 1178-6973 ;DOI: 10.2147/IDR.S449491 ;PMID: 38576823

Full text available

Citations Cited by
10
Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions
Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions
Material Type:
Article 		Add to My Research

Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions

Drug design, development and therapy, 2023-01, Vol.17, p.1097-1106 [Peer Reviewed Journal]

2023 Dong et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Dong et al. 2023 Dong et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S368590 ;PMID: 37064432

Full text available

Citations Cited by
11
Diagnosis and Screening of Patients with Fabry Disease
Diagnosis and Screening of Patients with Fabry Disease
Material Type:
Article 		Add to My Research

Diagnosis and Screening of Patients with Fabry Disease

Therapeutics and clinical risk management, 2020-01, Vol.16, p.551-558 [Peer Reviewed Journal]

2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Vardarli et al. 2020 Vardarli et al. ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S247814 ;PMID: 32606714

Full text available

Citations Cited by
12
Assessing the relationship between systemic immune-inflammation index and mortality in patients with hypertrophic cardiomyopathy
Assessing the relationship between systemic immune-inflammation index and mortality in patients with hypertrophic cardiomyopathy
Material Type:
Article 		Add to My Research

Assessing the relationship between systemic immune-inflammation index and mortality in patients with hypertrophic cardiomyopathy

Upsala journal of medical sciences, 2021, Vol.126, p.e8124-9 [Peer Reviewed Journal]

2021 The Author(s). Published by Upsala Medical Society. ;Publisher changed from Taylor & Francis, Ltd. © 2021. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Upsala Medical Society. 2021 ;ISSN: 0300-9734 ;EISSN: 2000-1967 ;DOI: 10.48101/ujms.v126.8124 ;PMID: 34984097

Full text available

Citations Cited by
13
Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis
Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis
Material Type:
Article 		Add to My Research

Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis

Pharmacogenomics and personalized medicine, 2021-01, Vol.14, p.823-837 [Peer Reviewed Journal]

COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Ma et al. 2021 Ma et al. ;ISSN: 1178-7066 ;EISSN: 1178-7066 ;DOI: 10.2147/PGPM.S314880 ;PMID: 34285551

Full text available

Citations Cited by
14
Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy
Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy
Material Type:
Article 		Add to My Research

Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy

Vascular health and risk management, 2010-01, Vol.6 (default), p.593-601 [Peer Reviewed Journal]

2010. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2010 Muratore and Baranchuk, publisher and licensee Dove Medical Press Ltd. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/vhrm.s8355 ;PMID: 20730015

Full text available

Citations Cited by
15
Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy
Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy
Material Type:
Article 		Add to My Research

Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy

Application of clinical genetics, 2014-01, Vol.7 (default), p.195-208 [Peer Reviewed Journal]

COPYRIGHT 2014 Dove Medical Press Limited ;COPYRIGHT 2014 Dove Medical Press Limited ;2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Roma-Rodrigues and Fernandes. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1178-704X ;EISSN: 1178-704X ;DOI: 10.2147/TACG.S49126 ;PMID: 25328416

Full text available

Citations Cited by
16
Misclassification of hypertrophic cardiomyopathy: validation of diagnostic codes
Misclassification of hypertrophic cardiomyopathy: validation of diagnostic codes
Material Type:
Article 		Add to My Research

Misclassification of hypertrophic cardiomyopathy: validation of diagnostic codes

Clinical epidemiology, 2017-01, Vol.9, p.403-410 [Peer Reviewed Journal]

COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Magnusson et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1179-1349 ;EISSN: 1179-1349 ;DOI: 10.2147/CLEP.S139300 ;PMID: 28848363

Full text available

Citations Cited by
17
Clinical Presentation and 6-Month Outcomes of Patients with Peripartum Cardiomyopathy in Indonesia
Clinical Presentation and 6-Month Outcomes of Patients with Peripartum Cardiomyopathy in Indonesia
Material Type:
Article 		Add to My Research

Clinical Presentation and 6-Month Outcomes of Patients with Peripartum Cardiomyopathy in Indonesia

International journal of general medicine, 2024-03, Vol.17, p.1073-1083 [Peer Reviewed Journal]

2024 Prameswari et al. ;COPYRIGHT 2024 Dove Medical Press Limited ;2024 Prameswari et al. 2024 Prameswari et al. ;ISSN: 1178-7074 ;EISSN: 1178-7074 ;DOI: 10.2147/IJGM.S447214 ;PMID: 38529099

Full text available

Citations Cited by
18
Silent cerebral infarction in chronic heart failure: ischemic and nonischemic dilated cardiomyopathy
Silent cerebral infarction in chronic heart failure: ischemic and nonischemic dilated cardiomyopathy
Material Type:
Article 		Add to My Research

Silent cerebral infarction in chronic heart failure: ischemic and nonischemic dilated cardiomyopathy

Vascular health and risk management, 2008-04, Vol.4 (2), p.463-469 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Kozdag et al, publisher and licensee Dove Medical Press Ltd. 2008 ;ISSN: 1176-6344 ;ISSN: 1178-2048 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S2166 ;PMID: 18561522

Full text available

Citations Cited by
19
Identification of Novel Targets for Treatment of Dilated Cardiomyopathy Based on the Ferroptosis and Immune Heterogeneity
Identification of Novel Targets for Treatment of Dilated Cardiomyopathy Based on the Ferroptosis and Immune Heterogeneity
Material Type:
Article 		Add to My Research

Identification of Novel Targets for Treatment of Dilated Cardiomyopathy Based on the Ferroptosis and Immune Heterogeneity

Journal of inflammation research, 2023-01, Vol.16, p.2461-2476 [Peer Reviewed Journal]

2023 Lu et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Lu et al. 2023 Lu et al. ;ISSN: 1178-7031 ;EISSN: 1178-7031 ;DOI: 10.2147/JIR.S407588 ;PMID: 37334346

Full text available

Citations Cited by
20
The Many Faces of Arrhythmogenic Cardiomyopathy: An Overview
The Many Faces of Arrhythmogenic Cardiomyopathy: An Overview
Material Type:
Article 		Add to My Research

The Many Faces of Arrhythmogenic Cardiomyopathy: An Overview

Application of clinical genetics, 2023-11, Vol.16, p.181-203 [Peer Reviewed Journal]

COPYRIGHT 2023 Dove Medical Press Limited ;2023 Tadros et al. 2023 Tadros et al. ;ISSN: 1178-704X ;EISSN: 1178-704X ;DOI: 10.2147/TACG.S383446

Full text available

Citations Cited by

Results 1 - 20 of 368  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2009  (13)
  2. 2009 To 2012  (13)
  3. 2013 To 2016  (87)
  4. 2017 To 2021  (179)
  5. After 2021  (77)
  6. More options open sub menu

Resource Type 

  1. Articles  (345)
  2. Reports  (23)
  3. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait